← Back to Clinical Trials
Recruiting NCT05825027

NCT05825027 Risk Stratification in Children With Concussion

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05825027
Status Recruiting
Phase
Sponsor Duke University
Condition Concussion, Brain
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2023-05-23
Primary Completion 2028-02-28

Eligibility & Interventions

Sex All sexes
Min Age 11 Years
Max Age 17 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2023-05-23 with a primary completion date of 2028-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project will measure concussion symptoms, biological markers, and academic and social factors across the first year postconcussion to develop a model that enables early identification of and symptom management for children at higher risk for persistent postconcussive symptoms. Findings will provide novel insights into the longer-term effects of concussion on children's physical, psychological, and social well-being and support the development of personalized healthcare and school-based plans to reduce disparities in children's ability to return-to-learn and -play and improve postconcussion quality of life.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with concussion that occurred within the past 7 days * Glasgow Coma Scale (GCS) score between 13-15 * English speaking Exclusion Criteria: * Diagnosed with moderate or severe traumatic brain injury * Polytrauma * Nontraumatic brain injury * Pregnancy

Contact & Investigator

Central Contact

Karin Reuter-Rice, PhD

✉ karin.reuter-rice@duke.edu

📞 919-681-7647

Principal Investigator

Karin Reuter-Rice, PhD

PRINCIPAL INVESTIGATOR

Duke University School of Nursing

Frequently Asked Questions

Who can join the NCT05825027 clinical trial?

This trial is open to participants of all sexes, aged 11 Years or older, up to 17 Years, studying Concussion, Brain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05825027 currently recruiting?

Yes, NCT05825027 is actively recruiting participants. Contact the research team at karin.reuter-rice@duke.edu for enrollment information.

Where is the NCT05825027 trial being conducted?

This trial is being conducted at Durham, United States.

Who is sponsoring the NCT05825027 clinical trial?

NCT05825027 is sponsored by Duke University. The principal investigator is Karin Reuter-Rice, PhD at Duke University School of Nursing. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology